SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001739614-22-000048
Filing Date
2022-04-25
Accepted
2022-04-25 09:04:49
Documents
13
Period of Report
2022-04-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K inhibrx-20220425.htm   iXBRL 8-K 34198
2 EX-99.1 ex991inbxannouncessab.htm EX-99.1 18851
  Complete submission text file 0001739614-22-000048.txt   199660

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20220425.xsd EX-101.SCH 1926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20220425_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20220425_pre.xml EX-101.PRE 13059
7 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20220425_htm.xml XML 11432
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39452 | Film No.: 22847498
SIC: 2836 Biological Products, (No Diagnostic Substances)